On or around 04/16/2018 (Date of order of distribution of settlement)
Filing Date: May 08, 2015
According to the law firm press release, the lawsuit alleges Defendants made false and/or misleading statements and/or failed to disclose that: (1) the clinical research organization conducting the STEP Study lacked independence; (2) the trial drug supply for the STEP Study was shipped to clinical sites at lower temperatures than permitted by the drug specifications; and (3) as a result, of the foregoing, the Company’s public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.
Plaintiffs filed a consolidated complaint on February 8, 2016.
On August 4, 2016, the Court issued an Order granting without prejudice Defendants' Motion to Dismiss. Plaintiffs were given leave to file an amended complaint, which they did on September 27.
On January 31, 2017, the parties entered into a Stipulation of Settlement. The Settlement was preliminarily approved by the Court on April 5. On September 29, the Court granted final approval of the Settlement and dismissed this case with prejudice. On April 16, 2018, the Court issued an Order granting Plaintiffs' Motion for distribution of Settlement funds.
Company & Securities Information
Defendant: Ampio Pharmaceuticals, Inc.
Industry: Biotechnology & Drugs
Headquarters: United States
Ticker Symbol: AMPE
Company Market: New York SE
Market Status: Public (Listed)
About the Company & Securities Data
"Company" information provides the industry and sector classification and headquarters state for the primary company-defendant in the litigation. In general, "Securities" information provides the ticker symbol, market, and market status for the underlying securities at issue in the litigation.
In most cases, the primary company-defendant actually issued the securities that are the subject of the litigation, and the securities information and company information relate to the same entity. In a small subset of cases, however, the primary company-defendant is not the issuer (for example, cases against third party brokers/dealers), and the securities information and company information do not relate to the same entity.
First Identified Complaint
Guidano Napoli, et al. v. Ampio Pharmaceuticals, Inc., et al.